National Collaborative on Child Obesity Research. Childhood Obesity in the United States.http://www.nccor.org/downloads/ChildhoodObesity_020509.pdf.

Daviglus ML, Lloyd-Jones DM, Pirzada A. Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence. American Journal of Cardiovascular Drugs 2006;6:87-101. Rosenthal T, Gavras I. Fixed-drug combinations as first-line treatment for hypertension. Progress in Cardiovascular Disease 2006;48:416-25. Jamieson MJ, Naghavi M. Multi-constituent cardiovascular pills (MCCP) — challenges and promises of population-based prophylactic drug therapy for prevention of heart attack. Current Pharmaceutical Design 2007;13:1069-76. Athyros VG, Tziomalos K, Mikhailidis DP, et al. Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia? Expert Opinion on Pharmacotherapy 2007;8:2267-77. Franco OH, Karnik K, Bonneux L. The future of metabolic syndrome and cardiovascular disease prevention: polyhype or polyhope? Tales from the polyera. Hormone and Metabolic Research 2007;39:627-31.